查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1917817

化學資訊學市場－2026-2031年預測

Chemoinformatics Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計化學資訊學市場將從 2025 年的 68.17 億美元成長到 2031 年的 149.38 億美元，複合年成長率為 13.97%。

化學資訊學市場之所以重要，在於其作為化學、電腦科學和資訊科技交叉領域的跨領域地位。它涵蓋了計算方法、軟體工具和數據管理系統的開發與應用，旨在解決複雜的化學和生物學問題。化學資訊學的核心在於化學資訊的組織、分析、建模和視覺化，主要關注分子性質、結構和活性。該領域是現代研發的重要技術基礎，尤其是在製藥和生物技術等數據密集型產業。

推動市場擴張的根本因素是傳統藥物發現日益複雜且成本高昂，以及化學數據呈指數級成長。治療方法研發，迫切需要創新，這是推動市場擴張的主要因素。化學資訊學透過實現更快、更有效率的化合物篩檢、先導藥物最適化以及理化和藥理性質預測，直接應對了這一挑戰，從而緩解並加速了早期研發流程。虛擬篩檢技術的廣泛應用是加速這一進程的關鍵。這些計算方法能夠對龐大的分子庫進行In Silico評估，以篩選出具有最佳性質的化合物進行合成和生物學測試，從而顯著降低資源消耗和時間。

同時，對個人化醫療日益重視正成為市場發展的關鍵促進因素。向標靶治療的模式轉移需要深入了解化合物在特定生物環境中的行為。化學資訊學工具對於預測藥物-標靶相互作用、建立ADMET（吸收、分佈、代謝、排泄、毒性）模型以及識別患者特異性先導化合物至關重要，從而支持開發更有效、更安全的個人化治療方案。這一趨勢進一步推動了對先進預測分析和數據整合平台的需求。

從區域來看，北美已確立其主導地位，成為最成熟的市場。這一主導地位得益於其強大的生態系統，包括眾多大型製藥和生物技術公司、持續的大規模研發投入，以及眾多領先的軟體供應商和學術研究中心。該地區積極採用先進的計算技術，以保持藥物研發領域的競爭優勢，從而鞏固了其在化學資訊學領域的創新、商業性化應用和戰略夥伴關係的卓越中心地位。

儘管化學資訊學市場具有巨大的變革潛力，但由於其複雜性和成本高昂，該市場仍面臨許多推廣障礙。其中一個關鍵的阻礙因素是有效利用先進的化學資訊學平台需要大量的專業知識。許多工具需要高階計算知識，這造成了技能差距，阻礙了實驗室化學家和生物學家採用這些工具。此外，整體擁有成本也是一個障礙。這不僅包括專用軟體套件的授權費用，還包括對高效能運算基礎設施、資料儲存以及操作和解讀這些先進系統所需的技術人員的大量投資。對於小規模的研究機構和學術機構而言，這些財務和技術障礙可能會限制其獲取最尖端科技的機會。

競爭格局的特點是既有大型多元化生命科學技術供應商，也有專業軟體公司。領先企業在整合軟體平台的廣度和深度上展開競爭，這些平台涵蓋化學資料庫管理、分子建模、動態計算和預測分析等模組。成功取決於演算法的持續創新、使用者介面設計的改進（以提高易用性），以及與實驗室資訊管理系統 (LIMS) 和其他資料來源的無縫整合能力。提供強大、可擴展且合規的解決方案，進而提高科學研究效率，是企業的首要任務。

總之，化學資訊學市場是推動科學發現的重要基石，其發展與數據驅動調查方法的演進密不可分。製藥業對研發效率的不懈追求以及向個人化醫療的策略轉型，為化學資訊學的擴張提供了結構性支撐，而北美則扮演著重要的商業和創新中心角色。對於業內人士而言，策略重點應集中在三個方面：透過更直覺的軟體介面和整合的工作流程來彌合用戶體驗差距；透過開發基於雲端的擴充性解決方案來實現用戶可近性的普及；以及提升演算法能力，從而更準確地預測複雜的分子行為。成功與否取決於對終端用戶科研工作流程的深刻理解，以及提供能夠將海量化學數據無縫轉化為可操作、可靠洞察的工具的能力，從而為研發決策提供支援。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 化學資訊學工具市場

  • 介紹
  • 解決方案
  • 服務

第6章 按應用分類的化學資訊學市場

  • 介紹
  • 藥物發現
  • 臨床研究
  • 化學分析
  • 其他

第7章 按最終用戶分類的化學資訊學市場

  • 介紹
  • 製藥和生物技術公司
  • 研究和學術機構
  • 其他

第8章 區域化學資訊學市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • BioSolveIT GmbH
  • Dassault Systemes
  • Certara
  • Jubilant Biosys Inc.
  • OpenEye Scientific（Cadence Design Systems）
  • Schrodinger Inc
  • Collaborative Drug Discovery Inc
  • Genedata（Danaher Corporation）

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061615796

Chemoinformatics Market is projected to expand at a 13.97% CAGR, attaining USD 14.938 billion in 2031 from USD 6.817 billion in 2025.

The chemoinformatics market is defined by its critical role as an interdisciplinary field at the nexus of chemistry, computer science, and information technology. It encompasses the development and application of computational methods, software tools, and data management systems to solve complex chemical and biological problems. At its core, chemoinformatics is concerned with the organization, analysis, modeling, and visualization of chemical information, primarily focused on the properties, structures, and activities of molecules. This discipline serves as an indispensable technological backbone for modern research and development, particularly in data-intensive sectors like pharmaceuticals and biotechnology.

Market expansion is fundamentally driven by the escalating complexity and cost of traditional drug discovery, coupled with the exponential growth of chemical data. A primary catalyst is the pressing need to innovate in therapeutic development, especially for chronic and complex diseases. Chemoinformatics directly addresses this by enabling faster, more efficient compound screening, lead optimization, and the prediction of physicochemical and pharmacological properties, thereby de-risking and accelerating the early-stage pipeline. Integral to this acceleration is the widespread adoption of virtual screening techniques. These computational methods allow for the in-silico evaluation of vast molecular libraries against biological targets, prioritizing compounds with optimal characteristics for synthesis and biological testing, which dramatically reduces resource expenditure and time.

Concurrently, the rising strategic emphasis on personalized medicine is becoming a significant market driver. The paradigm shift towards targeted therapies requires a deep understanding of compound behavior in specific biological contexts. Chemoinformatics tools are essential for predicting drug-target interactions, modeling ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiles, and identifying patient-specific leads, thereby supporting the development of more effective and safer tailored treatments. This trend amplifies the demand for sophisticated predictive analytics and data integration platforms.

Geographically, North America is established as the dominant and most mature market. This leadership is underpinned by a powerful ecosystem comprising major pharmaceutical and biotechnology corporations, substantial and sustained R&D investment, and a high concentration of leading software vendors and academic research centers. The region's proactive adoption of advanced computational technologies to maintain competitive advantage in drug discovery consolidates its position as the central hub for innovation, commercial deployment, and strategic partnerships in the chemoinformatics space.

Despite its transformative potential, the market faces significant adoption barriers related to complexity and cost. A primary constraint is the substantial expertise required to effectively utilize advanced chemoinformatics platforms. Many tools demand significant computational knowledge, creating a skill gap that can hinder their adoption by bench chemists and biologists. Furthermore, the total cost of ownership can be prohibitive. This includes not only the licensing fees for specialized software suites but also the significant investment in high-performance computing infrastructure, data storage, and the skilled personnel needed to operate and interpret these sophisticated systems. For smaller research organizations and academia, these financial and technical hurdles can limit access to state-of-the-art capabilities.

The competitive landscape is characterized by a mix of large, diversified life science technology providers and specialized software firms. Key players compete on the breadth and depth of their integrated software platforms, which may encompass modules for chemical database management, molecular modeling, quantum mechanics calculations, and predictive analytics. Success hinges on continuous innovation in algorithms, user interface design to improve accessibility, and the ability to integrate seamlessly with laboratory information management systems (LIMS) and other data sources. Providing robust, scalable, and compliant solutions that enhance research productivity is paramount.

In conclusion, the chemoinformatics market is a dynamic and essential enabler of scientific discovery, whose growth is inextricably linked to the evolution of data-driven research methodologies. Expansion is structurally supported by the pharmaceutical industry's relentless pursuit of R&D efficiency and the strategic pivot towards personalized medicine, with North America serving as the primary commercial and innovation center. For industry experts, strategic focus must center on bridging the usability gap through more intuitive software interfaces and integrated workflows, developing cloud-based and scalable solutions to democratize access, and advancing algorithmic capabilities for more accurate prediction of complex molecular behaviors. Success requires a deep understanding of the end-user's scientific workflow and the ability to deliver tools that seamlessly translate vast chemical data into actionable, reliable insights for decision-making in research and development.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Chemoinformatics Market Segmentation

  • By Tools
  • Solutions
  • Services
  • By Application
  • Drug Discovery
  • Clinical Research
  • Chemical Analysis
  • Others
  • By End-User
  • Pharmaceuticals & Biotech Companies
  • Research & Academic Institutes
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CHEMOINFORMATICS MARKET BY TOOLS

  • 5.1. Introduction
  • 5.2. Solutions
  • 5.3. Services

6. CHEMOINFORMATICS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Drug Discovery
  • 6.3. Clinical Research
  • 6.4. Chemical Analysis
  • 6.5. Others

7. CHEMOINFORMATICS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Pharmaceuticals & Biotech Companies
  • 7.3. Research & Academic Institutes
  • 7.4. Others

8. CHEMOINFORMATICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Agilent Technologies Inc.
  • 10.2. Bio-Rad Laboratories Inc.
  • 10.3. BioSolveIT GmbH
  • 10.4. Dassault Systemes
  • 10.5. Certara
  • 10.6. Jubilant Biosys Inc.
  • 10.7. OpenEye Scientific (Cadence Design Systems)
  • 10.8. Schrodinger Inc
  • 10.9. Collaborative Drug Discovery Inc
  • 10.10. Genedata (Danaher Corporation)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations